DK1061929T3 - Farmaceutisk præparat på basis af syntetisk naturligt progesteron og östradiol samt fremgangsmåde til fremstilling deraf - Google Patents
Farmaceutisk præparat på basis af syntetisk naturligt progesteron og östradiol samt fremgangsmåde til fremstilling derafInfo
- Publication number
- DK1061929T3 DK1061929T3 DK99939161T DK99939161T DK1061929T3 DK 1061929 T3 DK1061929 T3 DK 1061929T3 DK 99939161 T DK99939161 T DK 99939161T DK 99939161 T DK99939161 T DK 99939161T DK 1061929 T3 DK1061929 T3 DK 1061929T3
- Authority
- DK
- Denmark
- Prior art keywords
- oestradiol
- pharmaceutical composition
- preparation
- synthetic natural
- composition based
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9802830A FR2775599B1 (fr) | 1998-03-09 | 1998-03-09 | Composition pharmaceutique a base de progesterone naturelle de synthese et d'oestradiol et son procede de preparation |
PCT/FR1999/000515 WO1999045932A1 (fr) | 1998-03-09 | 1999-03-08 | Composition pharmaceutique a base de progesterone naturelle de synthese et d'oestradiol et son procede de preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1061929T3 true DK1061929T3 (da) | 2005-08-29 |
Family
ID=9523802
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99939161T DK1061929T3 (da) | 1998-03-09 | 1999-03-08 | Farmaceutisk præparat på basis af syntetisk naturligt progesteron og östradiol samt fremgangsmåde til fremstilling deraf |
Country Status (13)
Country | Link |
---|---|
US (1) | US6656929B1 (da) |
EP (1) | EP1061929B1 (da) |
KR (1) | KR20010034573A (da) |
AT (1) | ATE293979T1 (da) |
AU (1) | AU3259099A (da) |
BR (1) | BR9908622A (da) |
CA (1) | CA2323696C (da) |
DE (1) | DE69924987T2 (da) |
DK (1) | DK1061929T3 (da) |
ES (1) | ES2246578T3 (da) |
FR (1) | FR2775599B1 (da) |
PT (1) | PT1061929E (da) |
WO (1) | WO1999045932A1 (da) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6544553B1 (en) | 1999-12-28 | 2003-04-08 | Watson Pharmaceuticals, Inc. | Dosage forms and methods for oral delivery of progesterone |
FR2821555B1 (fr) | 2001-03-01 | 2003-05-16 | Besins Int Lab | Progestatif co-micronise avec un tensioactif, composition pharmaceutique le comprenant, leurs procedes de fabrication et leurs utilisations |
US9375437B2 (en) | 2010-06-18 | 2016-06-28 | Lipocine Inc. | Progesterone containing oral dosage forms and kits |
US20110312927A1 (en) * | 2010-06-18 | 2011-12-22 | Satish Kumar Nachaegari | Progesterone Containing Oral Dosage Forms and Related Methods |
US8951996B2 (en) | 2011-07-28 | 2015-02-10 | Lipocine Inc. | 17-hydroxyprogesterone ester-containing oral compositions and related methods |
CA2856520C (en) | 2011-11-23 | 2021-04-06 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
AU2015264003A1 (en) | 2014-05-22 | 2016-11-17 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
KR20170040209A (ko) | 2014-07-29 | 2017-04-12 | 쎄러퓨틱스엠디, 인코퍼레이티드 | 경피 크림 |
CN107847506A (zh) | 2015-06-22 | 2018-03-27 | 来普卡公司 | 含17‑羟基孕酮酯的口服组合物和相关方法 |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
WO2017173044A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd Inc. | Steroid hormone compositions in medium chain oils |
CA3020153A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2399243A2 (fr) * | 1974-04-23 | 1979-03-02 | Aries Robert | Perfectionnements aux procedes, dispositifs et produits pour l'implantation d'hormones destinees a favoriser la croissance des animaux d'embouche |
US4755386A (en) * | 1986-01-22 | 1988-07-05 | Schering Corporation | Buccal formulation |
US5073374A (en) * | 1988-11-30 | 1991-12-17 | Schering Corporation | Fast dissolving buccal tablet |
DK95093D0 (da) * | 1993-08-20 | 1993-08-20 | Novo Nordisk As | Farmaceutisk formulering indeholdende et hormon |
DE4429374C1 (de) * | 1994-08-12 | 1996-02-01 | Jenapharm Gmbh | Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente |
DE19718012C1 (de) * | 1997-04-29 | 1998-10-08 | Jenapharm Gmbh | Verfahren zur Herstellung peroral anwendbarer fester Arzneiformen mit gesteuerter Wirkstoffabgabe |
-
1998
- 1998-03-09 FR FR9802830A patent/FR2775599B1/fr not_active Expired - Lifetime
-
1999
- 1999-03-08 ES ES99939161T patent/ES2246578T3/es not_active Expired - Lifetime
- 1999-03-08 PT PT99939161T patent/PT1061929E/pt unknown
- 1999-03-08 AT AT99939161T patent/ATE293979T1/de not_active IP Right Cessation
- 1999-03-08 AU AU32590/99A patent/AU3259099A/en not_active Abandoned
- 1999-03-08 BR BR9908622-0A patent/BR9908622A/pt not_active IP Right Cessation
- 1999-03-08 CA CA2323696A patent/CA2323696C/fr not_active Expired - Lifetime
- 1999-03-08 DK DK99939161T patent/DK1061929T3/da active
- 1999-03-08 DE DE69924987T patent/DE69924987T2/de not_active Expired - Lifetime
- 1999-03-08 EP EP99939161A patent/EP1061929B1/fr not_active Expired - Lifetime
- 1999-03-08 WO PCT/FR1999/000515 patent/WO1999045932A1/fr active IP Right Grant
- 1999-03-08 KR KR1020007010010A patent/KR20010034573A/ko not_active Application Discontinuation
- 1999-03-16 US US09/268,353 patent/US6656929B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE69924987T2 (de) | 2006-06-08 |
FR2775599A1 (fr) | 1999-09-10 |
EP1061929B1 (fr) | 2005-04-27 |
KR20010034573A (ko) | 2001-04-25 |
AU3259099A (en) | 1999-09-27 |
EP1061929A1 (fr) | 2000-12-27 |
ATE293979T1 (de) | 2005-05-15 |
BR9908622A (pt) | 2000-11-14 |
WO1999045932A1 (fr) | 1999-09-16 |
PT1061929E (pt) | 2005-09-30 |
FR2775599B1 (fr) | 2001-08-17 |
DE69924987D1 (de) | 2005-06-02 |
ES2246578T3 (es) | 2006-02-16 |
CA2323696C (fr) | 2010-04-27 |
CA2323696A1 (fr) | 1999-09-16 |
US6656929B1 (en) | 2003-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1061929T3 (da) | Farmaceutisk præparat på basis af syntetisk naturligt progesteron og östradiol samt fremgangsmåde til fremstilling deraf | |
EP0653795A3 (en) | Double-implanted MOS device with lateral diffusion and manufacturing method. | |
DK0735882T3 (da) | Kombinationsprodukt til kontraception indeholdende progesteronantagonister og gestagen | |
MY125467A (en) | Olanzapine dihydrate d | |
DK0577602T3 (da) | Transdermale antikonceptionelle formuleringer, fremgangsmåder og anordninger | |
DE69719360D1 (de) | Zusammensetzungen und methoden zur steigerung der darmfunktion | |
YU15299A (sh) | Farmaceutski sastavi | |
IT8820360A0 (it) | Protesi di giunzione ossea, in particolare giunzione dell'anca. | |
ID28003A (id) | Turunan-turunan adamantana | |
MX9805255A (es) | Antagonistas de receptor de vitronectina. | |
TR199801679T2 (xx) | Osteoporoz i�in birle�tirme terapisi. | |
SE9802973D0 (sv) | Immediate release tablet | |
RS49723B (sr) | Farmaceutska kompozicija koja sadrži entakapon ili nitekapon kao i umreženi derivat celuloze | |
AP1703A (en) | Heparin-derived polysaccharide mixtures, preparation method and pharmaceutical compositions containing same. | |
TR199801511T2 (xx) | Farmas�tik bile�im. | |
RS97604A (en) | New etonogestrel esters | |
HK1038508A1 (en) | Dosage form comprising liquid formulation | |
TW200501943A (en) | Escitalopram hydrobromide and a method for the preparation thereof | |
PT1235579E (pt) | Composicoes farmaceuticas contendo trimegestona | |
ES2170396T3 (es) | Composiciones farmaceuticas a base de diclofenac. | |
AR021249A1 (es) | COMPOSICIoN DE CONFITURA BLANDA NO PEGAJOSA. | |
GR20010100601A (el) | Προτυπα αναφορας για τον προσδιορισμο της καθαροτητας ή σταθεροτητας της μιλεινικης αμλοδιπινης και διεργασιες για αυτα. | |
EP1275379A3 (en) | Basic granulate comprising (7 alpha, 17 alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one | |
AP2000001950A0 (en) | Paroxetine maleate. | |
ES2179375T3 (es) | Composiciones farmaceuticas estabilizadas, a base de quinupristina y de dalfopristina y su preparacion. |